7155 results
Keyword Glimepiride EG Remove keyword
-
List item
Press release: Ferrer Internacional, S.A. withdraws its marketing authorisation application for Egrifta (tesamorelin)
Last updated: 26/06/2012authorisation application for Egrifta (tesamorelin … authorisation for the medicine Egrifta (tesamorelin), 2 mg, powder … for solution for injection. Egrifta was intended to be used for … -
List item
Generic and biosimilar medicines in the centralised procedure: 3rd EMA-EGA information day
London, 10/11/2010, Last updated: 09/11/2010centralised procedure: 3rd EMA-EGA information day … Generic medicines Association (EGA) on generic and biosimilar … one day event is open to EGA members only. Documents Agenda … -
List item
Second EMEA - EGA Info Day - Generic and Biosimilar Medicines in the Centralised Procedure
London, 03/10/2008, Last updated: 01/10/2008Second EMEA - EGA Info Day - Generic and Biosimilar … Documents Agenda - Second EMEA - EGA Info Day; Generic and Biosimilar … Centralised Procedure - For EGA Members Only PDF icon application/pdf … -
List item
EMEA - EGA Info Day on Generic and Biosimilar Medicinal Products and the Centralised Procedure
London, 25/11/2006, Last updated: 25/11/2006EMEA - EGA Info Day on Generic and Biosimilar … Documents Agenda - EMEA - EGA Info Day on Generic and Biosimilar … Centralised Procedure - For EGA members only PDF icon application/pdf … -
List item
Human medicine European public assessment report (EPAR): Victoza
liraglutide, Diabetes Mellitus, Type 2
Date of authorisation: 30/06/2009, Revision: 22, Authorised, Last updated: 29/04/2021its own was compared with glimepiride (a sulphonylurea). Victoza … controlling blood glucose than glimepiride. Results from this study show … 0.5 percentage points with glimepiride. In two ‘dual therapy’ … -
List item
Human medicine European public assessment report (EPAR): Segluromet
ertugliflozin l-pyroglutamic acid, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 23/03/2018, Revision: 6, Authorised, Last updated: 02/02/2023another diabetes medicine, glimepiride. In this study, HbA1c levels … ertugliflozin and 0.7 points with glimepiride. A lower dose of ertugliflozin … another diabetes medicine, glimepiride. In this study, HbA1c levels … -
List item
Human medicine European public assessment report (EPAR): Vokanamet
canagliflozin, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 23/04/2014, Revision: 20, Authorised, Last updated: 27/02/2023the secretion of insulin (e.g. sulphonylureas) the dose … other diabetes medicines, glimepiride and sitagliptin, after 52 … being deprived of oxygen (e.g. heart or respiratory failure … -
List item
Human medicine European public assessment report (EPAR): Steglatro
ertugliflozin l-pyroglutamic acid, Diabetes Mellitus, Type 2
Date of authorisation: 21/03/2018,
, Revision: 8, Authorised, Last updated: 06/12/2022
another diabetes medicine, glimepiride. HbA1c levels fell by 0.6 … ertugliflozin and 0.7 points with glimepiride. A lower dose of ertugliflozin … another diabetes medicine, glimepiride. HbA1c levels fell by 0.6 … -
List item
Human medicine European public assessment report (EPAR): Xiliarx
vildagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 19/11/2008, Revision: 22, Authorised, Last updated: 08/11/2022percentage points. When used with glimepiride (a sulphonylurea), Xiliarx … add-on to metformin plus glimepiride, Xiliarx reduced HbA1c levels … percentage points. When used with glimepiride (a sulphonylurea), Xiliarx … -
List item
Human medicine European public assessment report (EPAR): Galvus
vildagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 25/09/2007, Revision: 22, Authorised, Last updated: 26/10/2022percentage points. When used with glimepiride (a sulphonylurea), Galvus … add-on to metformin plus glimepiride, Galvus reduced HbA1c levels … percentage points. When used with glimepiride (a sulphonylurea), Galvus … -
List item
Human medicine European public assessment report (EPAR): Jalra
vildagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 19/11/2008, Revision: 23, Authorised, Last updated: 12/07/2022percentage points. When used with glimepiride (a sulphonylurea), Jalra … add-on to metformin plus glimepiride, Jalra reduced HbA1c levels … percentage points. When used with glimepiride (a sulphonylurea), Jalra … -
List item
Human medicine European public assessment report (EPAR): Velmetia
sitagliptin, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 16/07/2008, Revision: 35, Authorised, Last updated: 20/02/2023when used as an add-on to glimepiride (another sulphonylurea … sitagliptin was added to glimepiride and metformin, the levels … when used as an add-on to glimepiride (another sulphonylurea … -
List item
Human medicine European public assessment report (EPAR): Efficib
sitagliptin, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 15/07/2008, Revision: 32, Authorised, Last updated: 31/01/2023when used as an add-on to glimepiride (another sulphonylurea … sitagliptin was added to glimepiride and metformin, the levels … when used as an add-on to glimepiride (another sulphonylurea … -
List item
Human medicine European public assessment report (EPAR): Tesavel
sitagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 10/01/2008, Revision: 27, Authorised, Last updated: 02/02/2023other antidiabetes medicines: glimepiride (another sulphonylurea … studies, adding Tesavel to glimepiride (with and without metformin … antidiabetes medicines: glimepiride (another sulphonylurea … -
List item
Human medicine European public assessment report (EPAR): Xelevia
sitagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 21/03/2007, Revision: 37, Authorised, Last updated: 31/01/2023other antidiabetes medicines: glimepiride (another sulphonylurea … studies, adding Xelevia to glimepiride (with or without metformin … antidiabetes medicines: glimepiride (another sulphonylurea … -
List item
Human medicine European public assessment report (EPAR): Janumet
sitagliptin, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 16/07/2008,
Date of refusal: 18/02/2009, Revision: 29, Authorised, Last updated: 18/11/2022when used as an add-on to glimepiride (another sulphonylurea … sitagliptin was added to glimepiride and metformin, the levels … when used as an add-on to glimepiride (another sulphonylurea … -
List item
Human medicine European public assessment report (EPAR): Ristaben
sitagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 15/03/2010, Revision: 24, Authorised, Last updated: 01/07/2022other diabetes medicines: glimepiride (another sulphonylurea … studies, adding Ristaben to glimepiride (with or without metformin … other diabetes medicines: glimepiride (another sulphonylurea … -
List item
Human medicine European public assessment report (EPAR): Januvia
sitagliptin, Diabetes Mellitus, Type 2
Date of authorisation: 20/03/2007, Revision: 30, Authorised, Last updated: 30/06/2022other antidiabetes medicines: glimepiride (another sulphonylurea … studies, adding Januvia to glimepiride (with or without metformin … antidiabetes medicines: glimepiride (another sulphonylurea … -
List item
Human medicine European public assessment report (EPAR): Tarceva (updated)
erlotinib, Carcinoma, Non-Small-Cell Lung; Pancreatic Neoplasms
Date of authorisation: 19/09/2005, Revision: 32, Authorised, Last updated: 16/05/2023epidermal growth factor receptor (EGFR); patients with EGFR activating mutations whose … treat cancer); patients with EGFR activating mutations in whom … worked; patients without EGFR activating mutations in whom … -
List item
Human medicine European public assessment report (EPAR): Ristfor
sitagliptin, metformin hydrochloride, Diabetes Mellitus, Type 2
Date of authorisation: 15/03/2010, Revision: 25, Authorised, Last updated: 01/07/2022when used as an add-on to glimepiride (another sulphonylurea … sitagliptin was added to glimepiride and metformin, the levels … when used as an add-on to glimepiride (another sulphonylurea … -
List item
Human medicine European public assessment report (EPAR): Iressa
gefitinib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 24/06/2009, Revision: 15, Authorised, Last updated: 05/07/2022epidermal-growth-factor receptor (EGFR). How is Iressa used? Treatment … of cancer cells, such as EGFR on the surface of non-small-cell-lung-cancer … non-small-cell-lung-cancer cells. EGFR is involved in the growth … -
List item
Human medicine European public assessment report (EPAR): Orgalutran
ganirelix, Reproductive Techniques, Assisted; Ovulation Induction; Infertility, Female
Date of authorisation: 16/05/2000, Revision: 24, Authorised, Last updated: 04/04/2023ovulation (early release of eggs from the ovary) in women … so that they produce more eggs). In premature ovulation, the … ovulation, the ovaries release eggs that may be immature and … -
List item
Human medicine European public assessment report (EPAR): GONAL-f
follitropin alfa, Anovulation; Reproductive Techniques, Assisted; Infertility, Female; Hypogonadism
Date of authorisation: 20/10/1995, Revision: 25, Authorised, Last updated: 06/09/2022over) who do not produce eggs and do not respond to treatment … stimulates the ovaries to produce eggs); adult women who are undergoing … to produce more than one egg at a time; adult women with … -
List item
Human medicine European public assessment report (EPAR): Gefitinib Mylan
gefitinib, Carcinoma, Non-Small-Cell Lung
Date of authorisation: 27/09/2018,
, Revision: 5, Authorised, Last updated: 17/06/2022
epidermal growth factor receptor (EGFR). Gefitinib Mylan contains … of cancer cells, such as EGFR on the surface of non-small … non-small cell lung cancer cells. EGFR is involved in the growth … -
List item
Veterinary medicine European public assessment report (EPAR): Vectormune ND
cell-associated live recombinant turkey herpes virus (rHVT/ND) expressing the fusion protein of Newcastle diseases virus D-26 lentogenic strain, Chicken; Embryonated eggs
Date of authorisation: 08/09/2015, Revision: 7, Authorised, Last updated: 06/09/2021watery diarrhoea and reduced egg production. MD is a herpesvirus … directly into 18-day-old eggs containing embryos (unhatched … layers (chickens bred for egg production). For MD protection …